Expression of interleukin-33 and its receptor ST2 in periapical granulomas and radicular cysts

Journal of Oral Pathology and Medicine

Volumn 45, Issue 1, 2016, Pages 70-76

  Velickovic, Milena ^a   Pejnovic, Nada ^a   Petrovic, Renata ^b   Mitrovic, Slobodanka ^a   Jeftic, Ilija ^a   Kanjevac, Tatjana ^c   Lukic, Aleksandra ^c  

^a Center for Molecular Medicine   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c University of Kragujevac Medical Faculty   (Serbia)

Author keywords

Inflammation; Interleukin 33; Periapical granuloma; Radicular cyst; ST2

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE ANTIBODY; INTERLEUKIN 33; INTERLEUKIN 33 ANTIBODY; INTERLEUKIN RECEPTOR; RECEPTOR ANTIBODY; ST2 RECEPTOR; ST2 RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; CYTOKINE; IL1RL1 PROTEIN, HUMAN; IL33 PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR LIKE 1 PROTEIN;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR PATHOLOGY; MONONUCLEAR CELL; ODONTOGENIC CYST; PERIODONTIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TOOTH PERIAPICAL DISEASE; ADOLESCENT; BIOSYNTHESIS; EPITHELIUM CELL; INFLAMMATION; METABOLISM; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CYTOKINES; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-1 RECEPTOR-LIKE 1 PROTEIN; INTERLEUKIN-33; MALE; MIDDLE AGED; PERIAPICAL GRANULOMA; RADICULAR CYST; YOUNG ADULT;

EID: 84955747679     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12312     Document Type: Article

References (43)

1. Nair PN. Pathogenesis of apical periodontitis and the causes of endodontic failures. Crit Rev Oral Biol Med 2004; 15: 348-81.
2. Gao Z, Mackenzie IC, Rittman BR, et al. Immunocytochemical examination of immune cells in periapical granulomata and odontogenic cysts. J Oral Pathol 1988; 17: 84-90.
3. Lukic A, Arsenijevic N, Vujanic G, Ramic Z. Quantitative analysis of the immunocompetent cells in periapical granuloma: correlation with the histological characteristics of the lesions. J Endod 1990; 16: 119-22.
4. Marton IJ, Kiss C. Protective and destructive immune reactions in apical periodontitis. Oral Microbiol Immunol 2000; 15: 139-50.
5. Liapatas S, Nakou M, Rontogianni D. Inflammatory infiltrate of chronic periradicular lesions: an immunohistochemical study. Int Endod J 2003; 36: 464-71.
6. Kawashima N, Stashenko P. Expression of bone-resorptive and regulatory cytokines in murine periapical inflammation. Arch Oral Biol 1999; 44: 55-66.
7. Colic M, Vasilijic S, Gazivoda D, Vucevic D, Marjanovic M, Lukic A. Interleukin-17 plays a role in exacerbation of inflammation within chronic periapical lesions. Eur J Oral Sci 2007; 115: 315-20.
8. Colic M, Gazivoda D, Vucevic D, Vasilijic S, Rudolf R, Lukic A. Proinflammatory and immunoregulatory mechanisms in periapical lesions. Mol Immunol 2009; 47: 101-13.
9. Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23: 479-90.
10. Carriere V, Roussel L, Ortega N, et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci USA 2007; 104: 282-7.
11. Moussion C, Ortega N, Girard JP. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS ONE 2008; 3: e3331.
12. Sanada S, Hakuno D, Higgins L, et al. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 2007; 117: 1538-49.
13. Prefontaine D, Lajoie-Kadoch S, Foley S, et al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol 2009; 183: 5094-103.
14. Kobori A, Yagi Y, Imaeda H, et al. Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. J Gastroenterol 2010; 45: 999-1007.
15. Palmer G, Talabot-Ayer D, Lamacchia C, et al. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum 2009; 60: 738-49.
16. Sponheim J, Pollheimer J, Olsen T, et al. Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. Am J Pathol 2010; 177: 2804-15.
17. Bergers G, Reikerstorfer A, Braselmann S, et al. Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J 1994; 13: 1176-88.
18. Xu D, Chan WL, Leung BP, et al. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 1998; 187: 787-94.
19. Hayakawa H, Hayakawa M, Kume A, Tominaga S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 2007; 282: 26369-80.
20. Milovanovic M, Volarevic V, Ljujic B, et al. Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/c mice by enhancing polarization of APC to inflammatory phenotype. PLoS ONE 2012; 7: e45225.
21. Volarevic V, Mitrovic M, Milovanovic M, et al. Protective role of IL-33/ST2 axis in Con A-induced hepatitis. J Hepatol 2012; 56: 26-33.
22. Zdravkovic N, Shahin A, Arsenijevic N, et al. Regulatory T cells and ST2 signaling control diabetes induction with multiple low doses of streptozotocin. Mol Immunol 2009; 47: 28-36.
23. He X, Wu W, Lu Y, et al. Effect of interleukin-33 on Th1/Th2 cytokine ratio in peripheral lymphocytes in asthmatic mice. Chin Med J 2014; 127: 1517-22.
24. Xu D, Jiang HR, Kewin P, et al. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci USA 2008; 105: 10913-18.
25. Araujo-Pires AC, Francisconi CF, Biguetti CC, et al. Simultaneous analysis of T helper subsets (Th1, Th2, Th9, Th17, Th22, Tfh, Tr1 and Tregs) markers expression in periapical lesions reveals multiple cytokine clusters accountable for lesions activity and inactivity status. J Appl Oral Sci 2014; 22: 336-46.
26. Lin LM, Huang GTJ. Pathobiology of the periapex. In: Hargreaves K, Cohen S, eds. Pathways of the pulp, 10th edn. Mosby: Elsevier, 2011; 529-58.
27. Marcal JR, Samuel RO, Fernandes D, et al. T-helper cell type 17/regulatory T-cell immunoregulatory balance in human radicular cysts and periapical granulomas. J Endod 2010; 36: 995-9.
28. Buduneli N, Ozcaka O, Nalbantsoy A. Interleukin-33 levels in gingival crevicular fluid, saliva, or plasma do not differentiate chronic periodontitis. J Periodontol 2012; 83: 362-8.
29. Beklen A, Tsaosus Memet G. Interleukin-1 superfamily member, interleukin-33, in periodontal disease. Biotech Histochem 2014; 89: 209-14.
30. Köseoğlu S, Hatipoğlu M, Sağlam M, et al. Interlukin-33 could play an important role in the pathogenesis of periodontitis. J Periodontol Res 2014; 50: 525-34.
31. Link A, Vogt TK, Favre S, Britschgi MR, et al. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol 2007; 8: 1255-65.
32. Garlet GP, Horwat R, Ray HL Jr, et al. Expression analysis of wound healing genes in human periapical granulomas of progressive and stable nature. J Endod 2012; 38: 185-90.
33. Tschumperlin DJ. Fibroblasts and the ground they walk on. Physiology 2013; 28: 380-90.
34. Küchler AM, Pollheimer J, Balogh J, et al. Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation. Am J Pathol 2008; 173: 1229-42.
35. Tominaga S. A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett 1989; 258: 301-4.
36. Klemenz R, Hoffmann S, Werenskiold AK. Serum- and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen. Proc Natl Acad Sci USA 1989; 86: 5708-12.
37. Yagami A, Kanami O, Morita H, et al. IL-33 mediates inflammatory responses in human lung tissue cells. J Immunol 2010; 185: 5743-50.
38. Teixeira-Salum TB, Rodrigues DB, Gervasio AM, et al. Distinct Th1, Th2 and Treg cytokines balance in chronic periapical granulomas and radicular cysts. J Oral Pathol Med 2010; 39: 250-6.
39. de Paula-Silva FW, D'Silva NJ, da Silva LA, Kapila YL. High matrix metalloproteinase activity is a hallmark of periapical granulomas. J Endod 2009; 35: 1234-42.
40. Tajima S, Bando M, Ohno S, et al. ST2 gene induced by type 2 helper T cell (Th2) and proinflammatory cytokine stimuli may modulate lung injury and fibrosis. Exp Lung Res 2007; 33: 81-97.
41. Colic M, Lukic A, Vucevic D, et al. Correlation between phenotypic characteristics of mononuclear cells isolated from human periapical lesions and their in vitro production of Th1 and Th2 cytokines. Arch Oral Biol 2006; 51: 1120-30.
42. Hu WT, Li MQ, Liu W, et al. IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-κB and ERK1/2 signaling. Mol Hum Reprod 2014; 20: 358-72.
43. Velickovic M, Pejnovic N, Mitrovic S, Radosavljevic G, Jovanovic I, Kanjevac T, Jovicic N, Lukic A. ST2 Deletion Increases Inflammatory Bone Destruction in Experimentally Induced Periapical Lesions in Mice. J Endod 2015; 41: 369-75.